Alsoud D, Sabino J, Franchimont D, Cremer A, et al. Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study. Inflamm Bowel Dis 2024 Jan 12:izad315. doi: 10.1093.
PMID: 38215029